Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials
Marianne Zoghbi, Bharti Patel, Matthieu Roulleaux Dugage, Laura Mezquita, Rastilav Bahleda, Armelle Dufresne, Mehdi Brahmi, Isabelle Ray‐Coquard, Patricia Pautier, Jean Yves Blay, Axel Le Cesne, Christophe Massard, Benjamin Besse, Édouard Auclin, Elise F. Nassif (2024). Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials. , 16(23), DOI: https://doi.org/10.3390/cancers16234053.
Article52 days agoA randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L. Roland, Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka M. Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert S. Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis R. Ingram, Rohini R. Morey, Shadarra Crosby, Grace Mathew, Sheila L. B. Duncan, Cibelle Lima, Jean Yves Blay, Wolf H. Fridman, Kenna M. Shaw, Ignacio Wistuba, P. Andrew Futreal, Nadim J. Ajami, Jennifer A. Wargo, Neeta Somaiah (2024). A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. , 5(4), DOI: https://doi.org/10.1038/s43018-024-00726-z.
Article52 days agoA randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L. Roland, Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka M. Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert S. Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis R. Ingram, Rohini R. Morey, Shadarra Crosby, Grace Mathew, Sheila L. B. Duncan, Cibelle Lima, Jean Yves Blay, Wolf H. Fridman, Kenna M. Shaw, Ignacio Wistuba, P. Andrew Futreal, Nadim J. Ajami, Jennifer A. Wargo, Neeta Somaiah (2024). A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. , 5(4), DOI: https://doi.org/10.1038/s43018-024-00726-z.
Article52 days agoEarly phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials
Elise F. Nassif, Jean Yves Blay, Christophe Massard, Armelle Dufresne, Mehdi Brahmi, Philippe A. Cassier, Isabelle Ray‐Coquard, Patricia Pautier, Alexandra Léary, M.-P. Sunyach, Rastislav Bahleda, Antonin Lévy, C. Le Péchoux, Charles Honoré, Olivier Mir, Axel Le Cesne (2022). Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials. , 7(2), DOI: https://doi.org/10.1016/j.esmoop.2022.100425.
Article47 days ago83P Association of lung immune prognostic index (LIPI) with progression-free survival (PFS) in soft-tissue sarcoma (STS) patients treated with immunotherapy (IO) in early phase trials
Elise F. Nassif, Axel Le Cesne, Christophe Massard, Laura Mezquita, Matthieu Roulleaux Dugage, Rastilav Bahleda, Armelle Dufresne, Mehdi Brahmi, Isabelle Ray‐Coquard, Patricia Pautier, Alexandra Léary, Antonin Lévy, C. Le Péchoux, Charles Honoré, Olivier Mir, Benjamin Besse, Jean Yves Blay, Édouard Auclin (2021). 83P Association of lung immune prognostic index (LIPI) with progression-free survival (PFS) in soft-tissue sarcoma (STS) patients treated with immunotherapy (IO) in early phase trials. , 32, DOI: https://doi.org/10.1016/j.annonc.2021.10.101.
Article47 days ago